![]() VIARTIS
|
||
|
PARKINSON'S DISEASE |
||
|
|
||
|
|
PARKINSON'S DISEASE NEWS
|
|
|
MAY 2008 back to PARKINSON'S DISEASE home page 29th May 2008 - New clinical trial CLINICAL TRIAL OF SYN115 SYN-115 is a new type of drug
being tested for Parkinson's Disease that does not act by directly increasing
dopamine formation. SYN-115 is a potent and selective inhibitor of the A2A
receptor, which modulates the production of dopamine, glutamine and serotonin in
specific regions of the brain. In preclinical models of Parkinson's disease, A2A
inhibition has resulted in increased levels of dopamine, resulting in the
reversal of motor deficiencies.
For more information
go to
SYN115. Synosia is initiating a Phase
IIa clinical trial on SYN-115 and
plans to start a Phase IIb study during 2008.
While in this study, all participants will continue taking their routine
Parkinson's Disease medication. Images of the
brain, taken with an MRI, will be used to see if there are differences
26th May 2008 - New review ROTENONE AS A CAUSE OF PARKINSON'S DISEASE Rotenone is a pesticide that can cause Parkinson's Disease by lowering dopamine levels. Pesticides are known to be associated with an increased rate of Parkinson's Disease [1]. Common means : Rotenone is used
as an insecticide. There is a greatly increased likelihood of developing
symptoms by people involved in horticulture and agriculture
[2].
People with Parkinson’s Disease are more than twice as likely
to report heavy exposure to pesticides over their
lifetime as family members without Parkinson's Disease. Those
Means of toxicity : Rotenone inhibits tyrosine hydroxylation, which is essential for the formation of dopamine. So Rotenone causes Parkinson's Disease by lowering dopamine levels [4]. Symptoms : The neurochemical, neuropathological and behavioural features of Parkinson's disease [5]; hypokinesia and rigidity [6].
24th May 2008 - New review MERCURY AS A CAUSE OF PARKINSON'S DISEASE Mercury toxicity from a wide variety of sources is a known cause of symptoms that include those of Parkinson's Disease, especially tremor. It does this by lowering dopamine levels. Sources of mercury : dietary fish intake, ethnic over-the-counter medications, occupational exposures to mercury vapour, possession of dental amalgam fillings, gold production, skin ointment, some soaps. Means of toxicity : One of the chief targets of the toxin is the enzyme pyruvate dehydrogenase (PDH). The enzyme is irreversibly inhibited by several mercury compounds. The lipoic acid component of the multienzyme complex binds mercury compounds tightly and thus inhibits PDH. However, the cause of the symptoms of Parkinson's Disease is likely to be due to the fact that mercury potently causes the release of dopamine, thereby lowering dopamine levels. Symptoms : Parkinson’s
Disease
[1];
tremor
[2,
3]; hand
tremor, balance and gait disturbance with bradykinesia, paresthesias of the
upper extremities, neurobehavioral abnormalities, slight memory loss, and
spatial disorientation. Psychoneurological examination revealed dementia,
Parkinson's syndrome and ataxia of the lower limbs
[4];
tremor, paralysis, and excessive salivation as well as tooth loss, skin
problems, and pulmonary complaints
[5]; fine
22nd May 2008 - New research FATTY ACIDS REDUCE DEPRESSION IN PARKINSON'S DISEASE Journal of Affective Disorders 2008 May 14; [Epub ahead of print] (da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC.) Complete abstract Omega-3 fatty acids
are, like vitamins, essential for health and cannot be biosynthesized. So they
have to be consumed in the diet. Omega-3 fatty acids are present in high
quantities in some oils, such as fish oil. For more information go to
Omega-3 fatty acids. A
degree of depression is very common in Parkinson's Disease. The effect of
20th May 2008 - News release PROLONGED RELEASE ROPINIROLE
GlaxoSmithKline have announced the launch in the U.K. of ReQuip XL (ropinirole
prolonged-release tablets), which is a prolonged release version of
Requip. It
is the UK's only once-daily non-ergot oral dopamine agonist, providing
continuous delivery of ropinirole. Ropinirole prolonged-release is approved for
the treatment of idiopathic Parkinson's disease in people already taking
ropinirole immediate release tablets and in whom adequate symptomatic control has
been established. Clinical trials demonstrated that ropinirole prolonged-release
tablets are
18th May 2008 - New research THE COMPARISON OF TOLCAPONE AND ENTACAPONE CNS Neuroscience and Therapeutics [2008] 14 (1) : 83-93 (Lees AJ.) Complete abstract The COMT inhibitors
Entacopone (Comtan)
and
Tolcapone
prolong the effects of L-dopa, and so have been successfully used to complement
the use of L-dopa. The relative efficacy
of entacapone and tolcapone has not been adequately established.
A recent analysis of
14 studies in over 2500 patients,
conducted to assess the efficacy and safety of tolcapone and entacapone, found
both to be statistically superior to placebo in increasing
17th May 2008 - News report ATTITUDES TO THE USE OF STEM CELLS A huge survery was carried out in 15 countries on the knowledge of stem cell therapy and the attitudes to it, in: Austria, Czech Republic, Germany, Denmark, Spain, France, Ireland, Italy, Netherlands, Poland, United Kingdom, Sweden, U.S.A., Japan and Israel. The most knowledgeable were those in Sweden and Denmark, where 86% knew of stem cell research. Less than 45% of those in Poland, Austria, Israel and Japan even knew of it. Only about 40% to 50% of people had any real understanding of it. There was an even poorer understanding of how stem cells are extracted and the implications for the embryo, with U.S.A. at only 30%, being the most knowledegable. In most countries stem
cell research was viewed as useful. However, there were considerable
reservations about the risk of moral dilemnas. The Danish and Dutch believed
there to the least risk. Americans, Austrians and Japanese were at the other
extreme. Views regarding the morality of the use of stem cells differed a lot.
It was viewed as immoral by a majority in the
16th May 2008 - New review
CYANIDE AS A CAUSE OF PARKINSON'S DISEASE Common sources : Cyanide is
contained in drugs such as potassium cyanide and sodium cyanide. Cyanides can be
produced by certain bacteria, fungi, and algae, and are found in a number of
foods and plants. Cyanide occurs naturally in cassava roots (aka manioc), which
are potato-like tubers of cassava plants grown in tropical countries; these must
be processed prior to consumption (usually by extended boiling). Fruits that
have a pit, such as cherries or apricots, often contain either cyanides or
cyanogenic glycosides in the pit. Bitter almonds, from which almond oil
Means of toxicity : Cyanide interrupts the electron transport chain in the inner membrane of the mitochondrion because it binds more strongly than oxygen to the Fe3+ in cytochrome a3, preventing this cytochrome from combining electrons with oxygen. Cyanide also occupies the place of oxygen in hemoglobin (which transports oxygen). Oxygen is required for the formation of L-dopa. So carbon monoxide may cause Parkinson's Disease symptoms by interefering with the availability of oxygen to the brain. However, the precise means by which it causes Parkinson's Disease has still not been proven. Symptoms : Severe parkinsonian syndrome, characterized primarily by akinesia and rigidity [1]; Parkinsonism, that regressed slowly after the poisoning apart from dysarthria, bradykinesia of the upper limbs, and very brisk monosynaptic reflexes [2]; Progressive Parkinsonism, dystonia and apraxia of eye opening [3]; severe Parkinsonian syndrome [4]; a combination of severe parkinsonism and progressive dystonia [5]; severe parkinsonian symptoms, including profound micrographia and hypersalivation [6]; Parkinsonism that regressed slowly after the poisoning apart from dysarthria, bradykinesia of the upper limbs and very brisk monosynaptic reflexes [7]
12th May 2008 - New research
REIMPLANTATION GREATLY IMPROVES THE EFFECT OF
DBS SURGERY
DBS is a surgical method of treating
Parkinson's Disease that uses electrodes implanted into the brain. For
more information go to
Deep Brain Stimulation.
The misplacement of electrodes is a possible
explanation for a poor response to STN (bilateral subthalamic nucleus)
stimulation in some people with Parkinson Disease after DBS
surgery. A study was carried out to assess
whether reimplantation of the electrodes could produce improvement in
10th May 2008 - New research
RHINORRHEA IS INCREASED IN PARKINSON'S
DISEASE
Rhinorrhea is excessive liquid produced from
the nose.
For more information go to
Rhinorrhea.
Researchers found that rhinorrhea is increased in people with Parkinson's
Disease, but only a single publication supported this observation. So they
performed two further studies to assess the prevalence of rhinorrhea in
Parkinson's Disease. They also questioned subjects as to whether
rhinorrhea might be associated with olfactory impairment, which is
9th May 2008 - New research MORTALITY RATES IN PARKINSON'S DISEASE Neurology [2008] 70 (16 Pt 2) : 1423-1430 (Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G.) Complete abstract
Over
20,000 people were assessed in order
to evaluate the mortality rate in Parkinson disease. Over 500 of these
people had Parkinson's Disease. Each person with Parkinson's Disease was
matched with somebody who did not have Parkinson's Disease. Of those that
died within 6 years, nearly 36% of those with Parkinson's Disease had
died,
The researchers only asked yes or no for general health conditions (such as cerebral vascular disease). So they could not know how serious each person's condition was. They could therefore have matched somebody who had Parkinson's Disease with somebody who did not have Parkinson's Disease, with the Parkinson's Disease patient having far more serious cerebral vascular disease than the person that did not have Parkinson's Disease. The researchers also accepted self-reporting to determine their more than 500 Parkinson's Disease subjects, despite Parkinson's Disease being a widely misdiagnosed condition. They did not do a SPECT, and do not state that they even did a clinical examination in order to asses whether the subjects had Parkinson's Disease.
8th May 2008 - New book the stranger comes at sundown : living and dying with Parkinson's DiseaseJane Kriete Awalt
7th May 2008 - New research
FOOD CONTAMINANTS INCREASE PARKINSON'S
DISEASE Neurology. 2008 Apr 15;70(16 Pt 2):1423-30. Related Articles, LinkOut
This study aimed to investigate the
association of Parkinson's Disease with dietary exposure to
polychlorinated biphenyls (PCBs) and methylmercury (MeHg).
Polychlorinated
biphenyls have a wide range of industrial uses.
For more information go to
Polychlorinated
biphenyls. They
are known to be highly toxic and have caused large
scale environmental contaminations, particularly in the U.S.A.. Polluting
rivers caused fish to be contaminated.
Polychlorinated
biphenyls dumped in sewage plants was passed on as sludge to be used by
farmers and gardeners, leading to contaminated food supplies. The community used
to investigate the association were the Faeroe
Islands, a Danish territory north of
the British Isles. This is because the Faeroe Islands presently has the highest
incidence of
6th May 2008 - New research THE ARABIC ORIGINS OF GENETIC PARKINSON'S DISEASE Movement Disorders [2008] Apr 28 [Epub ahead of print] (Benamer HT, de Silva R, Siddiqui KA, Grosset DG.) Complete abstract
The present report systematically reviewed the medical literature
concerning Parkinson's Disease in Arabs. Over twenty studies were used.
The
prevalence of Parkinson's Disease
amongst Arabs was found to be only 27 to 43 people per 100,000. The
prevalence amongst Americans is up to 10 times greater than that. The
incidence of Parkinson's Disease amongst Arabs (the rate of diagnosis) is
reported at 4.5 per 100,000 people per year. The incidence is up to 5
times greater amongst
Americans. The reason for such very
low levels in
2nd May 2008 - History leonardo da vinci's descriptions of parkinson's diseaseThe Italian artist, engineer and scientist Leonardo da Vinci (1452-1519) also studied anatomy, physiology and medicine. Leonardo da Vinci kept secret notebooks in which he wrote and sketched his ideas and observations, in handwriting that only he could read. So keen was he to study the human body that he went out at night to dissect human corpses. For more information go to Leonardo da Vinci. Over 300 years before James Parkinson formally described Parkinson's Disease, Leonardo da Vinci saw people whose symptoms coincided with those seen in Parkinson's Disease. Leonardo wrote in his notebooks that "you will see.....those who.....move their trembling parts, such as their heads or hands without permission of the soul; (the) soul with all its forces cannot prevent these parts from trembling." In a translatiom of Da Vinci's notebooks "The movements of paralytics of those benumbed by cold, whose head and members move without control of the soul, who cannot stop the movements." The combination of difficulty with voluntary movement ("paraletici") and tremor ("tremanti') leave little doubt of the diagnosis of Parkinson's Disease. At the end of his life Leonardo was unable to paint due to the loss of control of movement in his hands. It has been suggested that, by then, Leonardo had the disorder himself. Due to most of his notebooks remaining secret for centuries, Leonardo did not receive any credit for contributing to the recognition of Parkinson's Disease. |
||
|
|
||
![]() |
||
| ©2006-2008 Viartis | ||
| mail@viartis.net | ||